Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CILOSTAZOL vs CILTACABTAGENE AUTOLEUCEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CILOSTAZOL vs CILTACABTAGENE AUTOLEUCEL: Safety Overview

Metric CILOSTAZOL CILTACABTAGENE AUTOLEUCEL
Total FAERS Reports 1,475 3,796
Deaths Reported 258 437
Death Rate 17.5% 11.5%
Hospitalizations 753 1,376
Average Patient Age 70.3 yrs 65.1 yrs
% Female Patients 40.6% 42.3%
FDA Approval Date Apr 20, 2006 N/A
Manufacturer Chartwell RX, LLC Janssen Biotech, Inc
Route ORAL INTRAVENOUS
Marketing Status Discontinued N/A